Orr Eran, Arbel Tal, Levy Miki, Sela Yaron, Weissberger Omer, Liran Omer, Lewis Jeremy
XR Health Inc, Brookline, USA.
XR Health Ltd, Tel Aviv, Israel.
Heliyon. 2023 Jul 7;9(7):e17870. doi: 10.1016/j.heliyon.2023.e17870. eCollection 2023 Jul.
Mental health is the second largest group of health disorders associated with prolonged disability. Treating conditions such as stress and anxiety are a global health challenge due to inadequate funding and resources. Therefore, providing virtual treatment in the metaverse may provide a novel method of treatment for these conditions. We conducted a retrospective analysis of health records of people experiencing stress and anxiety who were treated principally in the metaverse using virtual reality. The main objective was to determine if virtual mental health treatment was achievable and safe, with measurable outcomes repeated at multiple time points. Here, 61 participants health records were evaluated (50% were female, 19% male, 31% identified as other). The cohort was 45.7 ± 15.7 years of age and reported no adverse effects with outcomes measured. Specifically, anxiety (via Generalized Anxiety Disorder Scale) decreased by 34% (p = 0.002) and stress (via Perceived Stress Scale) decreased by 32% (p < 0.001) after virtual intervention. The data suggests that this method of treatment was feasible, safe, and outcomes were obtainable over a range of time points. This early data suggest that management in the metaverse for these conditions may be beneficial, however, further prospective studies are necessary to better understand these clinical findings.
心理健康是与长期残疾相关的第二大类健康障碍。由于资金和资源不足,治疗压力和焦虑等病症是一项全球性的健康挑战。因此,在元宇宙中提供虚拟治疗可能为这些病症提供一种新颖的治疗方法。我们对主要在元宇宙中使用虚拟现实进行治疗的压力和焦虑患者的健康记录进行了回顾性分析。主要目的是确定虚拟心理健康治疗是否可行且安全,以及在多个时间点是否能重复获得可测量的结果。在此,对61名参与者的健康记录进行了评估(50%为女性,19%为男性,31%为其他性别)。该队列的年龄为45.7±15.7岁,且报告在测量结果时无不良反应。具体而言,虚拟干预后,焦虑(通过广泛性焦虑障碍量表)下降了34%(p = 0.002),压力(通过感知压力量表)下降了32%(p < 0.001)。数据表明,这种治疗方法是可行、安全的,并且在一系列时间点都能获得结果。这些早期数据表明,在元宇宙中对这些病症进行管理可能是有益的,然而,需要进一步的前瞻性研究来更好地理解这些临床发现。